Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients after COVID-19.
Michał ChudzikMonika BurzyńskaJoanna KapustaPublished in: Nutrients (2022)
1-MNA supplementation significantly improved physical performance in a 6-min walk test and reduced the percentage of patients with severe fatigue after COVID-19. The comprehensive action of 1-MNA, including anti-inflammatory and anticoagulant effects, may be beneficial for the recovery of patients with persistent symptoms of fatigue and low tolerance to exercise after COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- sleep quality
- physical activity
- end stage renal disease
- high intensity
- anti inflammatory
- chronic kidney disease
- ejection fraction
- newly diagnosed
- respiratory syndrome coronavirus
- prognostic factors
- mental health
- peritoneal dialysis
- resistance training
- atrial fibrillation
- venous thromboembolism
- early onset
- patient reported outcomes
- body composition